Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Cardiac rhythm management devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Application trends
2.6 End-use
Chapter 3 Cardiac Rhythm Management Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of heart failure and other cardiac disorders
3.2.1.2 Technological advancements and introduction of innovative devices for cardiac rhythm monitoring
3.2.1.3 Increasing public awareness
3.2.1.4 Rising sedentary lifestyle
3.2.1.5 Favorable reimbursement scenario
3.2.1.6 Growing geriatric population base coupled with rising prevalence of obesity
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices
3.2.2.2 Product recalls
3.2.2.3 Stringent regulatory approvals
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Future market trends
3.9 Pricing analysis, 2022
3.10 Pipeline products
3.11 Indication landscape
3.12 Startup scenario
3.13 Number of pacemaker units, 2018 -2032
3.14 Number of Defibrillators units, 2018 -2032
3.15 Number of CRT devices units, 2018 -2032
3.16 Porter’s analysis
3.17 GAP analysis
3.18 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Cardiac Rhythm Management Devices Market Size and Forecast, By Product (USD Million)
5.1 Key technology trends
5.2 Pacemakers
5.2.1 Implantable pacemakers
5.2.2 External pacemakers
5.3 Defibrillators
5.3.1 Implantable cardioverter defibrillator (ICDs)
5.3.1.1 Transvenous implantable cardioverter defibrillator
5.3.1.1.1 Single-chamber ICDs
5.3.1.1.2 Dual-chamber ICDs
5.3.2 External Defibrillator
5.3.2.1 Manual external defibrillator
5.3.2.2 Automated external defibrillator
5.3.2.2.1 Semi-automated external defibrillator
5.3.2.2.2 Fully automated external defibrillator
5.3.2.3 Wearable cardioverter defibrillator
5.4 Cardiac Resynchronization Therapy Devices
5.4.1 Cardiac resynchronization therapy devices- D
5.4.2 Cardiac resynchronization therapy devices- P
Chapter 6 Cardiac Rhythm Management Devices Market Size and Forecast, By Application (USD Million)
6.1 Key application trends
6.2 Congestive heart failure
6.3 Arrhythmias
6.4 Bradycardia
6.5 Tachycardia
6.6 Others
Chapter 7 Cardiac Rhythm Management Devices Market Size and Forecast, By End-use (USD Million)
7.1 Key end-use trends
7.2 Hospitals
7.3 Cardiac care centers
7.4 Ambulatory surgical centers
7.5 Others
Chapter 8 Cardiac Rhythm Management Devices Market Size and Forecast, By Region (USD Million)
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of MEA
Chapter 9 Company Profiles
9.1 BIOTRONIK
9.2 ZOLL Medical Corporation (Asahi Kasei Group)
9.3 Boston Scientific Corporation
9.4 Abbott
9.5 Medtronic
9.6 Liva Nova
9.7 Schiller AG
9.8 Koninklijke Philips N.V.,
9.9 ABIOMED
9.10 Defibtech, LLC
9.11 Shree Pacetronix Ltd.
9.12 Osypka Medical
9.13 MicroPort Scientific Corporation
9.14 Medico S.R.L.
9.15 Vitatron
9.16 Stryker Corporation
9.17 CU Medical Systems Co. Ltd
9.18 Nihon Kohden Corporation
9.19 BPL Medical Technologies Pvt Ltd
9.20 AMI Italia
